TABLE 1.
Low-calorie diet (n = 9) |
Low-carbohydrate diet (n = 9) |
P value2 |
|||||
Before | After | Before | After | Group | Time | Group × time | |
Age (y) | 47 ± 123 | — | 42 ± 11 | — | 0.3614 | — | — |
Sex ratio (F:M) | 6:3 | — | 7:2 | — | 1.0005 | — | — |
Liver biopsy | |||||||
NAFLD activity score | 4.3 ± 1.8 | — | 5.8 ± 1.6 | — | 0.1604 | — | — |
Fibrosis stage | 1.3 ± 1.4 | — | 0.8 ± 0.9 | — | 0.3504 | — | — |
BMI (kg/m2) | 34 ± 9 | 33 ± 9 | 36 ± 4 | 35 ± 4 | 0.545 | <0.001 | 0.250 |
Body weight | |||||||
Absolute (kg) | 96 ± 21 | 92 ± 20 | 97 ± 14 | 92 ± 15 | 0.964 | <0.001 | 0.363 |
Fractional (%) | 100 | 96 ± 1 | 100 | 95 ± 1 | 0.239 | <0.001 | 0.239 |
Total cholesterol (mg/dL) | 207 ± 29 | 204 ± 53 | 212 ± 34 | 175 ± 24 | 0.607 | 0.242 | 0.498 |
Triglycerides (mg/dL) | 154 ± 65 | 115 ± 46 | 215 ± 90 | 103 ± 34 | 0.318 | 0.004 | 0.068 |
AST (U/L) | 56 ± 28 | 15 ± 4 | 50 ± 18 | 17 ± 2 | 0.303 | <0.001 | 0.596 |
ALT (U/L) | 77 ± 49 | 81 ± 45 | 80 ± 51 | 98 ± 25 | 0.799 | 0.382 | 0.754 |
AST:ALT ratio | 0.8 ± 0.2 | 0.2 ± 0.1 | 0.7 ± 0.2 | 0.2 ± 0.1 | 0.522 | <0.001 | 0.600 |
Fasting glucose (mg/dL) | 122 ± 55 | 106 ± 21 | 113 ± 34 | 87 ± 14 | 0.563 | 0.328 | 0.900 |
Hepatic TG content (%) | |||||||
Absolute | 19 ± 10 | 14 ± 7 | 22 ± 13 | 10 ± 7 | 0.988 | <0.001 | 0.049 |
Fractional | 100 | 72 ± 23 | 100 | 45 ± 14 | 0.008 | <0.001 | 0.008 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; NAFLD, nonalcoholic fatty liver disease; TG, triglyceride.
Analysis by 2-factor repeated-measures ANOVA unless otherwise indicated.
Mean ± SD (all such values).
Unpaired t test.
Fisher's exact test.